Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels.
Anthony DobiArthur DubernetMahary Lalarizo RakotoAnne-Laure Sandenon SeteyenDamien VagnerGrégorie LebeauLoïc RaffrayPhilippe GasquePublished in: Immunologic research (2022)